You have 9 free searches left this month | for more free features.

Biliary Tract Carcinomas

Showing 1 - 25 of 6,805

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bile cfDNA of Resectable Biliary Tract Carcinomas

Recruiting
  • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
  • Next generation sequencing
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Mar 13, 2023

Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

Active, not recruiting
  • Biliary Tract Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 1, 2022

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

Not yet recruiting
  • Biliary Tract Diseases
  • +5 more
  • no interventions
  • (no location specified)
Jun 1, 2023

Observational Monocentric Study on Biliary Tract Cancer (BABEL)

Recruiting
  • Biliary Tract Cancer
    • Roma, Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
    Jul 10, 2023

    LIver, Biliary tRAct and pancReatic Cancers

    Recruiting
    • Liver Cancer
    • +2 more
    • Blood drawing
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital, Zhejiang University School of Me
    Nov 14, 2023

    Predict the Response of Biliary Tract Tumors to Immunotherapy

    Recruiting
    • Biliary Tract Tumor
    • Cholangiocarcinoma
    • Blood samples, tumor biopsy specimens will be collected
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 22, 2023

    Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

    Not yet recruiting
    • Biliary Tract Neoplasms
    • Total Neoadjuvant Treatment
    • (no location specified)
    Sep 7, 2023

    Postoperative Recurrence in Biliary Tract Cancers:A Multicenter

    Recruiting
    • Biliary Tract Cancer
    • No intervention
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with NanJing Medical University
    Feb 15, 2023

    Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital Airport Hospital
    Apr 7, 2023

    Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • (no location specified)
    Apr 11, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

    Not yet recruiting
    • Carcinoma
    • +7 more
    • (no location specified)
    Nov 12, 2023

    Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)

    Recruiting
    • Biliary Tract Neoplasms
    • Immunotherapy
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jul 6, 2023

    Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • (no location specified)
    Apr 2, 2023

    Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)

    Active, not recruiting
    • Biliary Tract Neoplasms
    • +2 more
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 30, 2023

    Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Apr 26, 2023

      Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

      Recruiting
      • Advanced Biliary Tract Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 22, 2023

      Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

      Not yet recruiting
      • Biliary Tract Cancer
      • (no location specified)
      Aug 16, 2023

      Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Immune Checkpoint Inhibitors
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Oct 5, 2023

      AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary

      Recruiting
      • Biliary Tract Cancer
      • Blood drawing
      • Guangzhou, Guangdong, China
      • +1 more
      Dec 28, 2022

      Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

      Not yet recruiting
      • Locally Advanced Biliary Tract Cancer
      • Metastatic Biliary Tract Cancer
      • Camrelizumab and Apatinib Plus GP
      • Guangzhou, Guangdong, China
        Cancer center of SunYat-sen University
      Feb 15, 2023

      Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

      Not yet recruiting
      • Biliary Tract Carcinoma
      • Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Apr 10, 2023

      HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

      Not yet recruiting
      • HER2-positive Colorectal Cancer
      • HER2-positive Biliary Tract Cancer
      • Beijing, State*, China
        Peking University cancer hospital & institution
      Aug 2, 2023

      Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

      Not yet recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
        SKCCC Johns Hopkins
      Aug 16, 2023

      Trace Element Deficiency Trial in Ljubljana (trace elements)

      Recruiting
      • Trace Element Deficiency
      • trace elements
      • Ljubljana, Slovenia
        Institute of Oncology Ljubljana
      Sep 27, 2023